Localized and systemic forms of scleroderma in adults and children

Clinical and Experimental Rheumatology

Volumn 24, Issue SUPPL. 40, 2006, Pages

  Atzeni, F ^a   Bardoni, A ^b   Cutolo, M ^c   Hunzelmann, N ^d   Krieg, T ^d   Martini, G ^e   Montecucco, C ^b   Olski, T M ^d   Secchi, M E ^c   Valentini, G ^f   Zulian, F ^e   Sarzi Puttini, Piercarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF PADOVA   (Italy)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Diffuse and limited systemic scleroderma; Morphea; Scl 70 antibodies; Sclerosis in children; Skin fibrosis

Indexed keywords

AUTOANTIBODY;

AGE DISTRIBUTION; CAPILLAROSCOPY; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; EARLY DIAGNOSIS; GASTROINTESTINAL TRACT; HEART; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; JOINT; KIDNEY; LOCALIZED SCLERODERMA; LUNG; LYMPHOCYTIC INFILTRATION; MUSCLE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RAYNAUD PHENOMENON; REVIEW; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; SYMPTOM; SYSTEMIC SCLEROSIS; VALIDATION PROCESS;

ADULT; AUTOANTIBODIES; CHILD; HUMANS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC;

EID: 33645025426     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. SEIBOLD JR: Scleroderma. In: RUDDY S, HARRIS Jr ED, SLEDGE CB (Eds.): Kelley's Textbook of Rheumatology. 6th ed., Philadelphia: W.B. Saunders Company, 2001 pp. 1211-39.
2. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
3. GIORDANO M, VALENTINI G, MIGLIARESI S et al.: Different antibody patterns and different prognoses in patients with scleroderma, with various extent of skin sclerosis. J Rheumatol 1986; 13: 911-6.
4. FERRI C, VALENTINI G, COZZI F et al.: Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1.012 Italian patients. Medicine (Baltimore) 2002 ; 81: 139-53.
5. SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD JP et al.: Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002; 81: 154-67.
6. CLEMENTS J, FURST D: Eds. Systemic Sclerosis Lippincott Williams & Wilkins 2004.
7. VALENTINI G, MEDSGER TA, SILMAN AJ, BOMBARDIERI S: Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003; 21: S47-S48.
8. VALENTINI G, SILMAN AJ, VEALE D: Assessment of disease activity. Clin Exp Rheumatol 2003; 21: S39-41.
9. MEDSGER TA Jr, BOMBARDIERI S, CZIRJAK L et al.: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21: S42-6.
10. PICILLO U, MIGLIARESI S, MARCIALIS MR et al.: Clinical setting of patients with systemic sclerosis by serum autoantibodies. Clin Rheumatol 1997; 16: 378-83.
11. HO KT, REVEILLE JD: The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003; 5: 80-93.
12. STEEN VD: Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35-42.
13. BASU D, REVEILLE JD: Anti-scl-70. Autoimmunity 2005; 38: 65-72.
14. OKANO Y, STEEN VD, MEDSGER TA JR: Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993; 119: 1005-13.
15. KANG EH, LEE EB, KIM DJ, IM CH, LEE HJ, SONG YW: Anti-RNA polymerase antibodies in Korean patients with systemic sclerosis and their association with clinical features. Clin Exp Rheumatol 2005; 23: 731-2.
16. BARDONI A, ROSSI P, SALVINI R, BOBBIO-PALLAVICINI: Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. Clin Exp Rheumatol 2003; 21: 301-6.
17. VAN EENENNAAM H, VOGELZANGS JHP, BISSCHOPS L et al.: Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations. Clin Exp Immunol 2002; 130:532-40.
18. OVERZET K, GENSLER TJ, KIM S et al.: Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors during apoptosis. Arthritis Rheum 2000; 43: 1327-36.
19. TAMBY MC, CHANSEAUD Y, GUILLEVIN L, MOUTHON L: New insights into the pathogenesis of systemic sclerosis. Autoimm Rev 2003; 2: 152-7.
20. NISHIMA C, HAYAKAWA I, MATSUSHITA T et al.: Autoantibody against matrix metallo-proteinase-3 in patients with systemic sclerosis. Clin Exp Immunol 2004; 138: 357-63.
21. PLANQUE S, ZHOU Y, NISHIYAMA Y et al.: Autoantibodies to the epidermal growth factor receptor in systemic sclerosis, lupus and autoimmune mice. FASEB J 2003; 17: 136-43.
22. TAN FK, ARNETT FC, REVEILLE JD et al.: Autoantibodies to fibrillin-1 in systemic sclerosis. Ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles. Arthritis Rheum 2000; 43: 2464-71.
23. HENAULT J, TREMBLAY M, CLEMENT I, RAYMOND Y, SENECAL JL: Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 2004; 50: 3265-74.
24. TAKEHARA K, SATO S: Localized scleroderma is an autoimmune disorder. Rheumatology 2005; 44: 274-9.
25. SATO S, FUJIMOTO M, IHN H, KIKUCHI K, TAKEHARA K: Antigen specificity of antihistone antibodies in localized scleroderma Arch Dermatol 1994; 130: 1273-7.
26. STEEN VD, MEDSGER TA Jr: Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001; 44: 2828-35.
27. RODNAN GP, LIPINSKI E, LUKSICK J: Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979; 22: 130-40.
28. ENOMOTO DN, MEKKES JR, BOSSUYT PM, HOEKZEMA R, BOS JD: Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 1996; 35: 381-7.
29. NIVES PARODI M, CASTAGNETO C, FILACI G et al.: Plicometer skin test: a new technique for the evaluation of cutaneous involvement in systemic sclerosis. Br J Rheumatol 1997; 36: 244-50.
30. MOORE TL, LUNT M, MCMANUS B, ANDERSON ME, HERRICK AL: Seventeen-point dermal ultrasound scoring system - A reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology (Oxford) 2003: 42: 1559-63.
31. SANDQVIST G, AKESSON A, EKLUND M. Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil 2004; 26: 981-7.
32. TAKEHARA K: Treatment of early diffuse cutaneous systemic sclerosis patients in Japan by low-dose corticosteroids for skin involvement. Clin Exp Rheumatol 2004; 22 (Suppl. 33): S87-9.
33. KERSCHER M, VOLKENANDT M, MEURER M, LEHMANN P, PLEWIG G, ROCKEN M: Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet 1994;14:1233.
34. BOGOCH ER, GROSS DK: Surgery of the hand in patients with systemic sclerosis: outcomes and considerations. J Rheumatol 2005; 32: 642-8.
35. ZULIAN F, WOO P, ATHREYA BH et al.: Preliminary Classification Criteria for Systemic Sclerosis in children. In: ZULIAN F, RUPERTO N (Eds.): Proceedings of the II° International Workshop on "Nomenclature and Diagnostic Criteria for Juvenile Scleroderma Syndromes" 2004.
36. MARTINI G, FOELDVARI I, RUSSO R et al.: Systemic scleroderma syndromes in children: clinical and immunological characteristics of 181 patients. Arthritis Rheum 2003; 48: S512.
37. QUARTIER P, BONNET D, FOURNET JC et al.: Severe cardiac involvement in children with systemic sclerosis and myositis. J Rheumatol 2002; 29: 1767-73.
38. ARKACHAISRI T, SCALAPINO T, FERTIG N et al.: Comparison of clinical and serological findings in childhood and adult onset systemic sclerosis. Arthritis Rheum 2004; 50: S686-7.
39. UZIEL Y, FELDMAN BM, KRAFCHIK BR, YEUNG RS, LAXER RM: Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000; 136: 91-5
40. STRATTON RJ, WILSON H, BLACK CM: Pilot study of anti-thymocyte globulin plus my-cophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology (Oxford) 2001; 40: 84-8.
41. ZULIAN F, CORONA F, GERLONI V et al.: Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases. Rheumatology (Oxford) 2004; 43: 229-33.
42. PETERSON LS, NELSON AM, SU WPD: Sub-specialty clinics: rheumatology and dermatology. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995; 70: 1068-76
43. ZULIAN F, ATHREYA BH, LAXER RM et al.: Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford). 2005 in press.
44. SU WP, PERSON JR: Morphea profunda: a new concept and a histopathologic study of 23 cases. Am J Dermatopathol 1981; 3: 25 1-60.
45. ZULIAN F, VALLONGO C, WOO P: Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005; 52: 2873-81.
46. ZULIAN F: Scleroderma in children. Pediatr Clin N Am 2005; 52: 521-45.
47. KERSCHER M, VOLKENANDT M, GRUSS C et al.: Low dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-6.
48. HULSHOF MM, BOUWES BJN, BERGMAN W et al.: Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized scleroderma and systemic scleroderma. J Am Acad Dermatol 2000; 43: 1017-23.
49. GRASSI W, MEDICO PD, IZZO F, CERVINI C: Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 2001; 30: 397-402.
50. CUTOLO M, GRASSI W, MATUCCI CERINIC M: Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003; 48: 3023-30.
51. MARICQ HR: Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24: 1159-65.
52. COLWELL JA, HALUSSHKA PV, SARJI KE, LOPES-VIRELLA MF, SAGEL J: Vascular disease in diabetes. Pathophysiological mechanisms and therapy. Arch Intern Med 1979; 139: 225-30.
53. CUTOLO M, PIZZORNI C, SULLI A: Capillaroscopy. Bes Pract Res Clin Rheumatol 2005; 19: 437-52.
54. HOUTMAN PM, KALLENBERG CGM, FIDLER V, WOUDA AA: Diagnostic significance of nailfold capillary patterns in patients with RP: an analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986; 13: 556-63.
55. CHEN ZY, SILVER RM, AINSWORTH SK, DOBSON RL, RUST P, MARICQ HR: Association between fluorescent antinuclear anti-bodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984; 77: 812-22.
56. BUKHARI M, HOLLIS S, MOORE T, JAYSON MI, HERRICK AL: Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology (Oxford) 2000; 39: 506-12.
57. BOMBARDIERI S, MEDSGER TA Jr, SILMAN AJ, VALENTINI G: The assessment of the patient with systemic sclerosis. Introduction. Clin Exp Rheumatol 2003; 21: S24.
58. KAHALEH MB: Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004; 22 (Suppl. 33): S19-23.
59. CUTOLO M, SULLI A, PIZZORNI C, ACCARDO S: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 2: 155-60.